. 2016 Sep 22;375(12):1109-12.

doi: 10.1056/NEJMp1607591.

Toward a Shared Vision for Cancer Genomic Data

Robert L Grossman¹, Allison P Heath¹, Vincent Ferretti¹, Harold E Varmus¹, Douglas R Lowy¹, Warren A Kibbe¹, Louis M Staudt¹

Affiliations

Affiliation

¹ From the Center for Data Intensive Science, University of Chicago, Chicago (R.L.G., A.P.H.); the Ontario Institute for Cancer Research, Toronto (V.F.); Weill Cornell Medicine, Cornell University, New York (H.E.V.); and the National Cancer Institute, Bethesda, MD (D.R.L., W.A.K., L.M.S.).

PMID: 27653561
PMCID: PMC6309165
DOI: 10.1056/NEJMp1607591

Toward a Shared Vision for Cancer Genomic Data

Robert L Grossman et al. N Engl J Med. 2016.

. 2016 Sep 22;375(12):1109-12.

doi: 10.1056/NEJMp1607591.

Authors

Robert L Grossman¹, Allison P Heath¹, Vincent Ferretti¹, Harold E Varmus¹, Douglas R Lowy¹, Warren A Kibbe¹, Louis M Staudt¹

Affiliation

¹ From the Center for Data Intensive Science, University of Chicago, Chicago (R.L.G., A.P.H.); the Ontario Institute for Cancer Research, Toronto (V.F.); Weill Cornell Medicine, Cornell University, New York (H.E.V.); and the National Cancer Institute, Bethesda, MD (D.R.L., W.A.K., L.M.S.).

PMID: 27653561
PMCID: PMC6309165
DOI: 10.1056/NEJMp1607591

No abstract available

PubMed Disclaimer

Figures

**Figure 1.. Functionality and Utility of the National Cancer Institute Genomic Data Commons (GDC).**
The GDC will accept cancer genomic and clinical data from a number of different sources, harmonize the data using consistent bioinformatic pipelines, and allow users to make discoveries regarding the genetic basis of cancer and its impact in the clinic and potentially to identify patients whose tumor profiles make them eligible for particular clinical trials.

See this image and copyright information in PMC

Comment in

The Importance - and the Complexities - of Data Sharing.
Drazen JM, Morrissey S, Malina D, Hamel MB, Campion EW. Drazen JM, et al. N Engl J Med. 2016 Sep 22;375(12):1182-3. doi: 10.1056/NEJMe1611027. N Engl J Med. 2016. PMID: 27653569 No abstract available.

Cited by

MiRNA expression as outcome predictor in pediatric AML: systematic evaluation of a new model.
Ellson I, Martorell-Marugán J, Carmona-Sáez P, Ramos-Mejia V. Ellson I, et al. NPJ Genom Med. 2024 Aug 6;9(1):40. doi: 10.1038/s41525-024-00424-w. NPJ Genom Med. 2024. PMID: 39107334 Free PMC article.
Comparison of human pluripotent stem cell differentiation protocols to generate neuroblastoma tumors.
Cheng B, Fang W, Pastor S, March AR, Porras T, Wu HW, Velez M, Parekh C, Maris JM, Asgharzadeh S, Huang M. Cheng B, et al. Sci Rep. 2024 Oct 4;14(1):23050. doi: 10.1038/s41598-024-73947-y. Sci Rep. 2024. PMID: 39367051 Free PMC article.
Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a-based and Siglece-based vaccination induces antitumor immunity and inhibits metastasis.
Carter JA, Matta B, Battaglia J, Somerville C, Harris BD, LaPan M, Atwal GS, Barnes BJ. Carter JA, et al. J Immunother Cancer. 2023 Dec 22;11(12):e007935. doi: 10.1136/jitc-2023-007935. J Immunother Cancer. 2023. PMID: 38135347 Free PMC article.
SMAD4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis.
Loevenich LP, Tschurtschenthaler M, Rokavec M, Silva MG, Jesinghaus M, Kirchner T, Klauschen F, Saur D, Neumann J, Hermeking H, Jung P. Loevenich LP, et al. Cancer Res. 2022 Dec 16;82(24):4604-4623. doi: 10.1158/0008-5472.CAN-22-1247. Cancer Res. 2022. PMID: 36219392 Free PMC article.
A multi-layered computational structural genomics approach enhances domain-specific interpretation of Kleefstra syndrome variants in EHMT1.
Chi YI, Jorge SD, Jensen DR, Smith BC, Volkman BF, Mathison AJ, Lomberk G, Zimmermann MT, Urrutia R. Chi YI, et al. Comput Struct Biotechnol J. 2023 Oct 13;21:5249-5258. doi: 10.1016/j.csbj.2023.10.022. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 37954151 Free PMC article.

See all "Cited by" articles

References

1. Lawrence MS, Stojanov P, Mermel CH, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014; 505: 495–501. - PMC - PubMed
1. Shaw AT, Ou S-HI, Bang Y-J, et al. Crizotinib in ROS1-rearranged non–small-cell lung cancer. N Engl J Med 2014; 371: 1963–71. - PMC - PubMed
1. Larkin J, Ascierto PA, Dréno B, et al. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med 2014; 371: 1867–76. - PubMed
1. Wilson WH, Young RM, Schmitz R, et al. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat Med 2015; 21: 922–6. - PMC - PubMed
1. Taichman DB, Backus J, Baethge C, et al. Sharing clinical trial data — a proposal from the International Committee of Medical Journal Editors. N Engl J Med 2016; 374: 384–6. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

Z01 BC008905/ImNIH/Intramural NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Toward a Shared Vision for Cancer Genomic Data

Affiliation

Toward a Shared Vision for Cancer Genomic Data

Authors

Affiliation

Figures

Comment in

Similar articles

Cited by

References

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources